Glaxosmithkline Stock Forecast

Hold candidate since Jun 03, 2026

The GlaxoSmithKline stock price gained 1.47% on the last trading day (Wednesday, 3rd Jun 2026), rising from $49.00 to $49.72. During the last trading day the stock fluctuated 1.01% from a day low at $49.39 to a day high of $49.89. The price has fallen in 6 of the last 10 days and is down by -2.61% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 435 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $167.28 million.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $48.91 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -9.02% during the next 3 months and, with a 90% probability hold a price between $44.50 and $51.03 at the end of this 3-month period.

GSK Signals & Forecast

There are mixed signals in the stock today. The GlaxoSmithKline stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $50.41 and $52.27. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 1.47%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for GlaxoSmithKline stock

GlaxoSmithKline finds support from accumulated volume at $49.67 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.500 between high and low, or 1.01%. For the last week the stock has had daily average volatility of 1.49%.

Our recommended stop-loss: $46.92 (-5.62%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (GSK) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect GlaxoSmithKline PLC to open at $49.67, and during the day (based on 14 day Average True Range), to move between $49.24 and $50.20, which gives a possible trading interval of +/-$0.96 (+/-1.95%) up or down from last closing price. If GlaxoSmithKline PLC takes out the full calculated possible swing range there will be an estimated 1.95% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $49.67 (0.10%) than the resistance at $50.90 (2.37%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is GlaxoSmithKline PLC stock A Buy?

GlaxoSmithKline holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.333 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $49.67 ( 0.107%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk